Yao‐ming Huang
Papers
1
Total Citations
5
H-Index
1
About
Yao‐ming Huang is a leading figure in bioprocess development, with a primary focus on accelerating the clinical translation of novel therapeutics through high‐throughput cell culture technologies. His most cited work, a 2015 case study on a monoclonal antibody (mAb), demonstrates how leveraging high‐throughput systems can dramatically compress development timelines for early‐phase clinical material production. This contribution addresses a critical industry bottleneck: the need to advance an increasing number of complex biologics into the clinic without sacrificing quality or yield. By systematically optimizing cell culture parameters, Huang’s research provides a robust framework for streamlining the path from discovery to first-in-human trials. His work has garnered over 5 citations, reflecting its practical value for biopharmaceutical engineers and process scientists. Huang’s achievements underscore a commitment to bridging the gap between laboratory innovation and clinical application, making him a key resource for students and researchers seeking to understand how high‐throughput methodologies can transform the efficiency of biologic drug development.
Research Focus
Key Achievements
Top Papers
- 1